Last reviewed: June 5, 2026
Last updated: June 5, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide has gained significant attention as a medication for chronic weight management, with clinical trials showing average weight loss of 10-15% of body weight over 68 weeks. Originally developed for type 2 diabetes management, this glucagon-like peptide-1 (GLP-1) receptor agonist was later approved for weight loss in people without diabetes. PlexusDx offers compounded semaglutide injection starting at $149 per month, making this class of medication more accessible for those seeking personalized weight loss support.
How Semaglutide Actually Works for Weight Loss
Semaglutide functions as a GLP-1 receptor agonist, meaning it mimics a natural hormone your body produces after eating. This hormone signals your brain's appetite centers and slows stomach emptying, creating a prolonged feeling of fullness. When semaglutide activates GLP-1 receptors, it reduces hunger signals and decreases cravings, leading many patients to eat less without conscious restriction. The medication also helps stabilize blood sugar levels, which can reduce energy crashes that typically trigger overeating.
Beyond appetite suppression, semaglutide may improve how your body manages glucose and influence metabolic rate. Some research suggests it reduces visceral fat—the dangerous fat surrounding internal organs—more effectively than subcutaneous fat alone. This dual mechanism of reducing calorie intake while potentially enhancing metabolic efficiency makes semaglutide different from older weight loss drugs that relied on stimulation alone.
Clinical Evidence: What Real Studies Show
The STEP clinical trial program, which enrolled over 4,500 participants, demonstrated that semaglutide combined with lifestyle changes produced significant weight loss compared to placebo. Participants receiving the highest doses lost an average of 15.3% of their body weight over one year, with some patients experiencing losses exceeding 20%. Importantly, these results persisted when patients maintained the medication, and weight regain occurred gradually after discontinuation, suggesting sustained benefit during treatment.
Cardiovascular outcome studies have also shown that GLP-1 receptor agonists like semaglutide reduce the risk of major adverse cardiac events in people with obesity and diabetes. This suggests benefits extend beyond weight loss to overall metabolic health. However, individual responses vary significantly—genetics, metabolism, lifestyle factors, and starting weight all influence how much weight a person will lose. PlexusDx's Precision Peptide Genetic Test examines variants in GLP1R and other peptide-pathway genes to help predict your individual response potential.
Common Myths About Semaglutide Weight Loss
One widespread myth is that semaglutide causes weight loss automatically without any effort. In reality, the medication works best as a tool that supports behavioral change—it reduces the biological drive to overeat, but patients still need to make healthier food choices and increase physical activity. Another misconception is that compounded semaglutide is inferior to brand-name versions; both contain the same active ingredient when sourced from licensed 503A compounding pharmacies, as PlexusDx uses exclusively.
A third myth suggests that once you stop semaglutide, weight loss is permanent. Clinical evidence shows weight typically returns gradually after discontinuation unless lifestyle changes are maintained. Many patients benefit from continuing semaglutide long-term, similar to how people take blood pressure or cholesterol medications indefinitely. The idea that semaglutide is only for people with diabetes is false—it was explicitly approved for chronic weight management in people with obesity regardless of diabetes status. Finally, some believe higher doses always mean better results, but finding your optimal dose is more important than chasing the highest strength.
PlexusDx Semaglutide Injection: Personalized Access and Pricing
PlexusDx compounded semaglutide injection starts at $149 per month and is available in all 50 states without requiring insurance or a membership fee. The medication is prepared by licensed 503A compounding pharmacies, ensuring pharmaceutical-grade quality and safety standards. Patients can use HSA or FSA accounts to pay for treatment, making it financially accessible for those with these healthcare savings options. Your dose may need to go up as you progress through treatment, but your price remains flat—PlexusDx does not charge more as your therapeutic dose increases.
For those seeking even greater personalization, the Precision Peptide Genetic Test ($99 add-on after your first month) analyzes your genetic variants in GLP1R, GIPR, FTO, MC4R, and 10 other key pathways involved in appetite regulation and weight metabolism. This test maps 49 peptides across 14 biological pathways, providing 150+ genetic insights that help your PlexusDx clinician tailor your treatment protocol. Some patients may benefit from tirzepatide, a dual GLP-1 and GIP receptor agonist that works through additional pathways, or the GLP-Squared combination formula for enhanced results.
Is Semaglutide Weight Loss Right for You?
Semaglutide may be appropriate if you have a BMI of 27 or higher with at least one weight-related health condition, or a BMI of 30 or higher regardless of other health factors. However, good candidates are also those committed to making sustainable lifestyle changes—the medication amplifies the effects of better eating habits and exercise, but works best alongside these efforts. People with a personal or family history of thyroid cancer or multiple endocrine neoplasia type 2 should discuss alternatives with their clinician, as semaglutide carries a specific contraindication for these populations.
Common side effects include nausea, which typically decreases over the first few weeks as your body adjusts, along with occasional constipation or decreased appetite for favorite foods. Most side effects are mild and manageable, especially when starting with a low dose and increasing gradually. PlexusDx clinicians work with you throughout your treatment to monitor your response, adjust your dose safely, and switch to alternative formulations if needed. An initial consultation can determine whether semaglutide injection, oral semaglutide, tirzepatide, or a combination approach aligns with your health goals and genetic profile.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Will I lose weight immediately after starting semaglutide?
Most patients notice appetite reduction within the first 1-2 weeks, but measurable weight loss typically becomes apparent after 4-8 weeks as dietary changes accumulate. The medication works gradually by reducing hunger and cravings, so weight loss accelerates as you consistently eat fewer calories.
How does semaglutide compare to other weight loss medications?
Semaglutide is a GLP-1 receptor agonist that works through appetite suppression and metabolic pathways, while older medications like phentermine primarily use stimulation.
What makes PlexusDx semaglutide more affordable than brand-name options?
PlexusDx uses licensed 503A compounding pharmacies to prepare semaglutide at a lower cost than brand-name Ozempic or Wegovy, starting at just $149 per month with no insurance needed. All 50 states are served, and HSA/FSA accounts are eligible.
Are there serious side effects from semaglutide weight loss therapy?
Serious side effects are rare; most people experience mild nausea, constipation, or temporary appetite loss that resolve within weeks. Severe pancreatitis and gallbladder issues occur in less than 1% of users.
How can the Precision Peptide Genetic Test improve my semaglutide results?
The Precision Peptide Genetic Test ($99 add-on) examines your GLP1R, GIPR, FTO, and MC4R variants—key genes influencing how your body responds to semaglutide and other peptide therapies.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Why Do GLP-1 Agonists Cause Diarrhea?
Which GLP-1 is Oral? Understanding Oral Semaglutide and Its Benefits